AU5931600A - Lcat recombinant cell line compositions and methods - Google Patents

Lcat recombinant cell line compositions and methods

Info

Publication number
AU5931600A
AU5931600A AU59316/00A AU5931600A AU5931600A AU 5931600 A AU5931600 A AU 5931600A AU 59316/00 A AU59316/00 A AU 59316/00A AU 5931600 A AU5931600 A AU 5931600A AU 5931600 A AU5931600 A AU 5931600A
Authority
AU
Australia
Prior art keywords
lcat
methods
cell line
recombinant cell
line compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59316/00A
Inventor
Thomas C. Becker
Steven B. Lane
Anice E. Thigpen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Betagene Inc
Original Assignee
Betagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betagene Inc filed Critical Betagene Inc
Publication of AU5931600A publication Critical patent/AU5931600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59316/00A 1999-07-14 2000-07-13 Lcat recombinant cell line compositions and methods Abandoned AU5931600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14392799P 1999-07-14 1999-07-14
US60143927 1999-07-14
PCT/US2000/019047 WO2001005943A2 (en) 1999-07-14 2000-07-13 Lcat recombinant cell line compositions and methods

Publications (1)

Publication Number Publication Date
AU5931600A true AU5931600A (en) 2001-02-05

Family

ID=22506305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59316/00A Abandoned AU5931600A (en) 1999-07-14 2000-07-13 Lcat recombinant cell line compositions and methods

Country Status (2)

Country Link
AU (1) AU5931600A (en)
WO (1) WO2001005943A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2489731T1 (en) 2007-07-26 2014-12-31 Amgen Inc. Patent Operations, M/S 28-2-C Modified lecithin-cholesterol acyltransferase enzymes
UA112151C2 (en) * 2009-06-12 2016-08-10 МедІммун, ЕлЕлСі USE OF LATH FOR THE TREATMENT OF ANEMIA AND DYSFUNCTION OF RED BLOOD CELLS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049488A (en) * 1985-11-08 1991-09-17 Genentech, Inc. Method and nucleic acid for the preparation of lecithin:cholesterol acyltransferase
WO1997017434A2 (en) * 1995-11-09 1997-05-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity

Also Published As

Publication number Publication date
WO2001005943A2 (en) 2001-01-25
WO2001005943A3 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU5520399A (en) Method and arrangement for switching cells
AU6864600A (en) Fuel cell
AU3731600A (en) Composition and structures made therefrom
AU1802901A (en) Improvement in cathodic protection system
AU5634300A (en) Composition and films thereof
AU4318000A (en) Agarobiose-containing composition
AU2349399A (en) R-lansoprazole compositions and methods
AU1290501A (en) Composition
AU1403501A (en) Novel composition and use
AU2035601A (en) Load cell
AU2001293074A1 (en) Human liver cell line
AU1152601A (en) Compositions and their use
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU4800800A (en) Fuel compositions
AU2346800A (en) Compositions and methods using cell fusion
AU1582801A (en) Methods and compositions for protection against bovine herpesvirus
AU2844801A (en) Fuel compositions
AU6094200A (en) Nor gene compositions and methods for use thereof
AU8243798A (en) Agm-derived stroma cells
AU5931600A (en) Lcat recombinant cell line compositions and methods
AU6310600A (en) Composition
AU6866400A (en) Bleacher composition
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use
AUPO982097A0 (en) Methods and compositions for use therein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase